Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaetane Nocturne

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Rheumatic Diseases Clinics of North America|July 20, 2016
Use of Biologics in Sjögren's SyndromeGaetane Nocturne, Divi Cornec, Raphaèle Seror, et al.
Clinical Reviews in Allergy & Immunology|June 1, 2017
Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?Kristina Schreiber, Gaetane Nocturne, Divi Cornec, et al.
Rheumatology (Oxford, England)|December 30, 2022
Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacityLoïc Meudec, Pauline Richebé, Juliette Pascaud, et al.
Cellular & Molecular Immunology|October 31, 2019
JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesisGaetane Nocturne, Juliette Pascaud, Bineta Ly, et al.
Annals of the Rheumatic Diseases|May 14, 2020
Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab aloneKevin Chevalier, Rakiba Belkhir, Raphaele Seror, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2025
Macrophage Cell Culture and Characterization by Serum Human AB in Health and DiseaseAudrey Paoletti, Bineta Ly, Samuel Bitoun, et al.
Plos One|June 16, 2025
JAK inhibitor withdrawal causes a transient pro-inflammatory cascade: A potential mechanism for major adverse cardiac eventsIlya Gurevic, Loic Meudec, Xavier Mariette, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
JAK Inhibitor Withdrawal Causes a Transient Proinflammatory Cascade: A Potential Mechanism for Major Adverse Cardiac EventsIlya Gurevic, Loic Meudec, Xavier Mariette, et al.
Joint Bone Spine|March 25, 2022
Answer to Giraud et al. "On the use of 18F FDG PET-CT in spondyloarthritis." Joint Bone Spine 2022;89:105377 and to Falsetti et al. "Polymyalgia Rheumatica: a syndrome with an enthesitic subset?" Joint Bone Spine 2022;89:105378Gaetane Nocturne, Florent L Besson, Marie Pean De Ponfilly-Sotier, et al.
Frontiers in Medicine|December 19, 2022
<sup>18</sup>F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?Marie Pean De Ponfilly-Sotier, Raphaële Seror, Gaetane Nocturne, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Rheumatic Diseases Clinics of North America|July 20, 2016
Use of Biologics in Sjögren's SyndromeGaetane Nocturne, Divi Cornec, Raphaèle Seror, et al.
Clinical Reviews in Allergy & Immunology|June 1, 2017
Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?Kristina Schreiber, Gaetane Nocturne, Divi Cornec, et al.
Rheumatology (Oxford, England)|December 30, 2022
Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacityLoïc Meudec, Pauline Richebé, Juliette Pascaud, et al.
Cellular & Molecular Immunology|October 31, 2019
JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesisGaetane Nocturne, Juliette Pascaud, Bineta Ly, et al.
Annals of the Rheumatic Diseases|May 14, 2020
Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab aloneKevin Chevalier, Rakiba Belkhir, Raphaele Seror, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 21, 2025
Macrophage Cell Culture and Characterization by Serum Human AB in Health and DiseaseAudrey Paoletti, Bineta Ly, Samuel Bitoun, et al.
Plos One|June 16, 2025
JAK inhibitor withdrawal causes a transient pro-inflammatory cascade: A potential mechanism for major adverse cardiac eventsIlya Gurevic, Loic Meudec, Xavier Mariette, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
JAK Inhibitor Withdrawal Causes a Transient Proinflammatory Cascade: A Potential Mechanism for Major Adverse Cardiac EventsIlya Gurevic, Loic Meudec, Xavier Mariette, et al.
Joint Bone Spine|March 25, 2022
Answer to Giraud et al. "On the use of 18F FDG PET-CT in spondyloarthritis." Joint Bone Spine 2022;89:105377 and to Falsetti et al. "Polymyalgia Rheumatica: a syndrome with an enthesitic subset?" Joint Bone Spine 2022;89:105378Gaetane Nocturne, Florent L Besson, Marie Pean De Ponfilly-Sotier, et al.
Frontiers in Medicine|December 19, 2022
<sup>18</sup>F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?Marie Pean De Ponfilly-Sotier, Raphaële Seror, Gaetane Nocturne, et al.
Pageof 10